Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Recombinant new coronavirus vaccine (CHO cells) high-dose group
BIOLOGICAL
2 trials
Sponsors
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Conditions
Coronavirus
Phase 1
Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine
NCT04445194
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Coronavirus
Start: 2020-06-22
End: 2021-09-20
Updated: 2020-12-03
Phase 2
Clinical Study of Recombinant Novel Coronavirus Vaccine
NCT04466085
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Coronavirus
Start: 2020-07-12
End: 2021-12-15
Updated: 2020-12-03
Related Papers
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
2021-03-24
353 citations